Pharmalucence, Inc. Announces FDA Approval and Orphan Drug Designation for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Malignant Melanoma Patients
8/16/2012 8:17:29 AM
More...
|
Pharmalucence, Inc. Partners with Robert Bosch Packaging Technology, Inc. to Supply State-of-the-Art Isolated Filling Equipment for Its New Drug Production Facility in Billerica, MA
7/29/2011 10:11:53 AM
More...
|
Pharmalucence, Inc. Announces FDA Approval for Use of Sulfur Colloid Injection to Locate Lymph Nodes in Breast Cancer Patients
7/25/2011 7:19:27 AM
More...
|
Pharmalucence, Inc. with Integrated Project Services (IPS) for Design and Construction of State-of-the-Art Pharmaceutical Production Facility in Billerica, MA
7/7/2011 10:10:06 AM
More...
|
Pharmalucence, Inc. To Build State-Of-The-Art Drug Production Facility; 25 to 30 New Jobs
6/8/2010 7:24:40 AM
More...
|
Company Profile for Pharmalucence, Inc.
6/4/2010 11:53:09 AM
More...
|
Pharmalucence, Inc. Announces FDA Approval for its Generic Sestamibi Kit
7/20/2009 10:00:02 AM
More...
|